VICO-trial: Video Consultations in the Follow-up of Children With Functional Abdominal Pain Disorders
Condition(s) studied
Investigational drug(s) / intervention(s)
Video consultation: Participants will have their follow-up consultation with the physician via video. The consultation takes place via the participant's/parent's own device.
Face-to-face consultation: The follow-up consultation with the physician will take place at the hospital.
Study summary
The goal of this non-inferiority randomized controlled multi-center trial is to investigate the use of video consultations in the follow-up care of children aged 4 - 18 years old with functional abdominal pain disorders (FAPDs). Video consultations will be compared to face-to-face consultations. Clinical outcomes and patients' and parents' healthcare experience will be compared between both groups.
Primary outcome is adequate relief after 12 weeks: the hypothesis is that video consultations are not inferior to face-to-face consultations regarding clinical outcomes and that adequate relief will be the same for both groups.
Participants and/or parents will be asked to complete a diary for 1 week and a questionnaire after every consultation: at baseline, after 6 weeks and after 12 weeks.
Eligibility
Primary outcome measure(s)
- Adequate relief — After 12 weeks
Proportion of participants reporting adequate relief. Adequate relief is a patient-reported outcome. Participants will be asked at 6 weeks and 12 weeks whether they have adequate relief of their Functional Abdominal Pain Disorder related complaints using a binary outcome (yes/no). Participants will complete a diary for a week and participants will be asked about adequate relief in the diary on day 7.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Amsterdam UMC, location AMC | Amsterdam | Netherlands | Recruiting |
More Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) trials in the Netherlands
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06665867 on ClinicalTrials.gov ↗ ← All trials in the Netherlands